## Abstract ## BACKGROUND. Cleavage of membraneโanchored heparinโbinding epidermal growth factorโlike growth factor (proHBโEGF) yields a soluble HBโEGF isoform (sHBโEGF), which is an activating epidermal growth factor receptor (EGFR) ligand and a Cโterminal fragment HBโEGFโC acting directly in the
Growth factors and bladder cancer: Clinical implications of the interactions between growth factors and their urothelial receptors
โ Scribed by Dr. Edward M. Messing
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 910 KB
- Volume
- 8
- Category
- Article
- ISSN
- 8756-0437
No coin nor oath required. For personal study only.
โฆ Synopsis
Growth factors (GFs) are a class of proteins that bind to specific cell surface receptors (GF-Rs), inducing a variety of responses including mitosis, in susceptible target cells. Abnormal production, expression, and/or function of GFs or GF-Rs can result in unregulated growth, the hallmark of malignant transformation. This chapter reviews those GFs/GF-Rs that have been linked to human bladder cancer. It focuses particularly on one [epidermal growth factor (EGF), which is excreted in urine in high concentrations] and its possible role in the development and growth of urothelial malignancy. Potential clinical applications in diagnosis, staging, prevention, and treatment are discussed.
๐ SIMILAR VOLUMES
Growth factors may play an important role in tumour growth and angiogenesis by their influence on tumour cell proliferation or their effect on neovascularization. The aim of the present study was to determine which of the growth factors, growth-inhibiting factors, and their receptors investigated in